["{\n\"step_by_step_thinking\": \"Based on the given data, we can see that as the dose of the novel chemotherapeutic agent increases, both the number of patients demonstrating improvement and the number of patients experiencing treatment-related adverse events also increase. This suggests a dose-response relationship.\n\nThe therapeutic index is calculated by dividing the maximum tolerated dose (MTD) by the minimally effective dose (MED). From the data provided, we can see that the MED appears to be around 20-30 mg, as this is where the majority of patients demonstrate improvement. The MTD seems to be around 100 mg, as this is where the highest rate of treatment-related adverse events occurs.\n\nUsing these values, we can calculate the therapeutic index:\n\nTherapeutic Index = MTD / MED\n= 100 mg / 20-30 mg\n= approximately 2.67\n\nThis suggests that a dose of 80-90 mg would be a good balance between efficacy and safety.\",\n\"answer_choice\": D"]